Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers
NCT03851341
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
COMBINATION_PRODUCT:
Janumet XR tablet 100/1000 mg
COMBINATION_PRODUCT:
GLH1SM tablet 100/1000 mg
Sponsor
GL Pharm Tech Corporation